Scott B. Ullem is CVP, Chief Financial Officer of Edwards Lifesciences Corp. Currently has a direct ownership of 39,898 shares of EW, which is worth approximately $2.95 Million. The most recent transaction as insider was on May 03, 2024, when has been sold 634 shares (Common Stock) at a price of $85.06 per share, resulting in proceeds of $53,928. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.9K
31.3% 3M change
30.55% 12M change
Total Value Held $2.95 Million

Scott B. Ullem Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 03 2024
SELL
Payment of exercise price or tax liability
$53,928 $85.06 p/Share
634 Reduced 3.32%
18,440 Common Stock
Apr 30 2024
SELL
Open market or private sale
$624,007 $86.07 p/Share
7,250 Reduced 27.54%
19,074 Common Stock
Apr 30 2024
BUY
Exercise of conversion of derivative security
$266,437 $36.75 p/Share
7,250 Added 21.59%
26,324 Common Stock
Apr 01 2024
SELL
Open market or private sale
$690,385 $95.16 p/Share
7,255 Reduced 27.56%
19,074 Common Stock
Apr 01 2024
BUY
Exercise of conversion of derivative security
$266,621 $36.75 p/Share
7,255 Added 21.6%
26,329 Common Stock
Feb 29 2024
SELL
Open market or private sale
$620,955 $85.59 p/Share
7,255 Reduced 27.56%
19,074 Common Stock
Feb 29 2024
BUY
Exercise of conversion of derivative security
$266,621 $36.75 p/Share
7,255 Added 21.6%
26,329 Common Stock
Feb 16 2024
SELL
Payment of exercise price or tax liability
$14,970 $86.04 p/Share
174 Reduced 0.9%
19,074 Common Stock
Feb 01 2024
SELL
Open market or private sale
$567,993 $78.29 p/Share
7,255 Reduced 27.37%
19,248 Common Stock
Feb 01 2024
BUY
Exercise of conversion of derivative security
$266,621 $36.75 p/Share
7,255 Added 21.49%
26,503 Common Stock
Dec 29 2023
SELL
Open market or private sale
$1,110,740 $76.55 p/Share
14,510 Reduced 42.98%
19,248 Common Stock
Dec 29 2023
BUY
Exercise of conversion of derivative security
$533,242 $36.75 p/Share
14,510 Added 30.06%
33,758 Common Stock
Oct 31 2023
SELL
Open market or private sale
$454,598 $62.66 p/Share
7,255 Reduced 27.37%
19,248 Common Stock
Oct 31 2023
BUY
Exercise of conversion of derivative security
$266,621 $36.75 p/Share
7,255 Added 21.49%
26,503 Common Stock
Sep 29 2023
SELL
Open market or private sale
$504,512 $69.54 p/Share
7,255 Reduced 27.37%
19,248 Common Stock
Sep 29 2023
BUY
Exercise of conversion of derivative security
$266,621 $36.75 p/Share
7,255 Added 21.49%
26,503 Common Stock
Aug 31 2023
SELL
Open market or private sale
$564,366 $77.79 p/Share
7,255 Reduced 27.37%
19,248 Common Stock
Aug 31 2023
BUY
Exercise of conversion of derivative security
$266,621 $36.75 p/Share
7,255 Added 21.49%
26,503 Common Stock
Jul 31 2023
SELL
Open market or private sale
$611,959 $84.35 p/Share
7,255 Reduced 27.37%
19,248 Common Stock
Jul 31 2023
BUY
Exercise of conversion of derivative security
$266,621 $36.75 p/Share
7,255 Added 21.49%
26,503 Common Stock
Jun 30 2023
SELL
Open market or private sale
$676,673 $93.27 p/Share
7,255 Reduced 27.37%
19,248 Common Stock
Jun 30 2023
BUY
Exercise of conversion of derivative security
$266,621 $36.75 p/Share
7,255 Added 21.49%
26,503 Common Stock
May 17 2023
SELL
Bona fide gift
-
8,496 Reduced 30.62%
19,248 Common Stock
May 11 2023
BUY
Grant, award, or other acquisition
-
9,450 Added 25.41%
27,744 Common Stock
May 10 2023
SELL
Open market or private sale
$7,165,353 $88.79 p/Share
80,700 Reduced 81.52%
18,294 Common Stock

Also insider at

BERY
BERRY GLOBAL GROUP, INC. Consumer Cyclical
ILMN
ILLUMINA, INC. Healthcare
SBU

Scott B. Ullem

CVP, Chief Financial Officer
Irvine, CA

Track Institutional and Insider Activities on EW

Follow Edwards Lifesciences Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW